Follow the Medicofarma Biotech S.A. stock price and the full directors' dealings record of the company, a listed issuer based in Poland. Shares trade on the PL market, under the oversight of KNF. The latest transaction was filed on 23 July 2026 (Sale). Among the most active insiders: MEDICOFARMA S.A.. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Medicofarma Biotech S.A. is a biopharmaceutical company focused on developing innovative health solutions. It is listed on the XWAR market.